Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Rises By 129.3%

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 153,400 shares, a growth of 129.3% from the November 30th total of 66,900 shares. Based on an average daily trading volume, of 47,600 shares, the short-interest ratio is presently 3.2 days. Currently, 3.0% of the shares of the company are sold short.

BioRestorative Therapies Price Performance

Shares of BRTX opened at $1.55 on Friday. The company’s fifty day moving average price is $1.52 and its 200-day moving average price is $1.63. BioRestorative Therapies has a 1-year low of $1.03 and a 1-year high of $3.67. The firm has a market capitalization of $10.73 million, a PE ratio of -1.01 and a beta of 62.59.

BioRestorative Therapies (NASDAQ:BRTX) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.22. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The business had revenue of $0.23 million for the quarter, compared to the consensus estimate of $0.30 million. As a group, research analysts anticipate that BioRestorative Therapies will post -1.43 EPS for the current fiscal year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.